Supplementary figures and tables: Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis.docx

<b>Supplementary
Figure 1</b>. Real-world Evidence Comparing Oral Anticoagulants in
Non-valvular Atrial Fibrillation: A Systematic Review and Network
Meta-analysis

<b><i>‘Risk of Bias
Assessment Results by Outcome for Studies Included in Base-case Analysis
Using Risk of Bias in Non-randomized Studies of Interventions’</i></b>
<b><i> </i></b>
<b>Supplementary
Figure 2. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<b><i>‘Risk of Bias
Assessment Results by Domain for Studies Included in Base-case Analysis Using
Risk of Bias in Non-randomized Studies of Interventions’ </i></b>
<b> </b>
<b>Supplementary
Figure 3. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<b><i>‘Network
Meta-analysis Results for Ischemic Stroke’ </i></b>
<b> </b>
<b>Supplementary
Figure 4. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<b>‘<i>Network Meta-analysis
Results for Intracranial Hemorrhage’</i></b>
<b> </b>
<b>Supplementary
Figure 5.</b> Real-world Evidence Comparing Oral Anticoagulants in
Non-valvular Atrial Fibrillation: A Systematic Review and Network
Meta-analysis

<b><i>‘Network
Meta-analysis Results for Gastrointestinal Bleeding’</i></b><b><i><br></i></b>

<b>Supplementary
Figure 6.</b> Real-world Evidence Comparing Oral Anticoagulants in
Non-valvular Atrial Fibrillation: A Systematic Review and Network
Meta-analysis

<b><i>‘Network
Meta-analysis Results for All-cause Mortality’</i></b>
<b> </b>
<b>Supplementary Table
1. </b> Real-world Evidence Comparing
Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review
and Network Meta-analysis

‘<b><i>Search
Strategy’</i></b>
<b> </b>
<b>Supplementary
Table 2. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<b><i>‘Population,
Interventions and Comparisons, Outcomes, Study Design, and Time Period
Selection Criteria’</i></b>
<b> </b>
<b>Supplementary
Table 3. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<b><i>‘Process for
Selecting Data among Kin Publications’</i></b>
<b><i> </i></b>
<b>Supplementary
Table 4. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic
Review and Network Meta-analysis

<b><i>‘Key
Characteristics from Studies Included in the Network Meta-analysis’</i></b>
<b><i> </i></b>
<b>Supplementary
Table 5. </b> Real-world Evidence
Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A
Systematic Review and Network Meta-analysis

<i>‘<b>Outcomes from
Studies Included in the Network Meta-analysis’</b></i>
<b> </b>
<b>PRISMA checklist. </b> Real-world Evidence Comparing Oral
Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and
Network Meta-analysis

<b><i>‘PRISMA 2020 Checklist’ </i></b>